Revolution Medicines · 16 hours ago
Associate Director, Biostatistics - Late Stage
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Associate Director, Biostatistics will serve as a study level statistician for oncology studies in clinical late-stage development, providing leadership in biostatistical activities and collaborating across functions to contribute to program-level decision-making.
Health CareLife ScienceMedical
Responsibilities
Represent biostatistics on study and cross-functional project teams, providing statistical leadership
Lead and manage biostatistical activities to ensure consistency, scientific rigor, and timely deliverables
Provide statistical expertise for design, analysis and reporting of clinical studies
Develop statistical analysis plans and analysis specifications; ensure analyses align with clinical and regulatory objectives
Collaborate with statistical programming to ensure that analysis is conducted per statistical plan and specifications and delivered with high quality
Collaborate with data management and clinical operations to ensure robust CRF and database development and quality data collection
Provide statistical input to the development of global health authority documents, regulatory interaction, and response to health authority submissions
Influence strategy and inform decision-making through data-driven insights and clear communication of risk and benefit
Collaborate in publications, assist in data interpretation, and ensure consistency and accuracy in data presentation
Contribute to the development of functional-level standards, SOPs, and templates
Keep abreast in new developments in statistics, drug development, and regulatory guidance and share knowledge with functional and cross-functional team members
Qualification
Required
Ph.D. or M.S. in Statistics/Biostatistics, a minimum of 5 years (for Ph.D.) and 8 years (for M.S.) of experience in biotech/pharma industry as a statistician. Level will be determined based on the relevance of experience
Hands-on experience in design and analysis of late-stage oncology trials is a must
Ability to work independently and within a team
Solid knowledge in ICH and other regulatory requirements related to biostatistical activities and clinical trials
Excellent verbal and written communication skills are required
Good interpersonal and project management skills are essential
Proficiency in SAS and/or R
Preferred
Hands-on experience in design and analysis of phase 3 oncology trials is desirable
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase